Zhang, Y., Zeng, G., Pan, H., Li, C., Hu, Y., Chu, K., . . . Zhu, F. (2021). Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infectious Diseases, 21(2), 181-193.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Zhang, Yanjun, et al. "Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in Healthy Adults Aged 18-59 Years: A Randomised, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial."
Lancet Infectious Diseases 21, no. 2 (2021): 181-193.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Zhang, Yanjun, et al. "Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in Healthy Adults Aged 18-59 Years: A Randomised, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial."
Lancet Infectious Diseases, vol. 21, no. 2, 2021, pp. 181-193.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.